SLNO

Soleno Therapeutics researches and develops treatments for rare genetic disorders, particularly focusing on conditions that affect metabolism and development. The company creates experimental drugs that undergo clinical testing with patients who have these specific medical conditions. It generates revenue through research funding, clinical trial partnerships, and aims to eventually sell approved treatments to healthcare systems and patients.